4-Methylisoquinoline-5-sulfonyl chloride → HCID 22121916, 화합물

반응식

C(OC([N:8]1[CH2:14][CH2:13][CH2:12][NH:11][CH:10]([CH2:15][CH3:16])[CH2:9]1)=O)(C)(C)C.[Cl:17][S:18]([C:21]1[CH:30]=[CH:29][CH:28]=[C:27]2[C:22]=1[C:23]([CH3:31])=[CH:24][N:25]=[CH:26]2)(=[O:20])=[O:19]>>[ClH:17].[CH2:15]([CH:10]1[CH2:9][NH:8][CH2:14][CH2:13][CH2:12][N:11]1[S:18]([C:21]1[CH:30]=[CH:29][CH:28]=[C:27]2[C:22]=1[C:23]([CH3:31])=[CH:24][N:25]=[CH:26]2)(=[O:19])=[O:20])[CH3:16]

참가 물질

반응물 2

HCID 154871104-Methylisoquinoline-5-sulfonyl chloride

HCID 221218911-(Tert-butoxycarbonyl)-3-ethyl-hexahydro-1h-1,4-diazepine

생성물 1

HCID 22121916HCID 22121916, 화합물수율 34.5%

실험 절차

Using 0.68 g of 1-(tert-butoxycarbonyl)-3-ethyl-hexahydro-1H-1,4-diazepine and 0.72 g of 5-chlorosulfonyl-4-methylisoquinoline, the procedure of Example 1 was otherwise repeated to provide 0.38 g of the objective compound (white crystals).

출처 및 근거

ORD 기록: ord-61d1178f408d48f3954b6546e4942c8b
출처 데이터셋: uspto-grants-2000_11
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06153608

반응 노트

불러오는 중…